MIRA Pharmaceuticals, Inc. (MIRA)
NASDAQ · Manufacturing · Pharmaceutical preparations
$0.8879+$0.0484 (+5.77%) on the dayAs of the close; data may be delayed.
MIRA price, last 12 months
Key stats
- Previous close
- $0.8395
- Open
- $0.8600
- Day range
- $0.8401 – $0.9200
- 52-week range
- $0.6000 – $2.45
- Volume
- 88.6K
- Avg volume (20 days)
- 1.7M
- Market cap
- $37.8M
Performance
1W+6.7%
1M+18.4%
3M−12.1%
6M−16.2%
YTD−41.2%
1Y−34.2%
vs S&P 500, 1Y−51.0 pts
Technicals and fundamentals
About MIRA Pharmaceuticals, Inc.
Mira Pharmaceuticals Inc is a clinical-stage pharmaceutical development company focused on developing novel oral small-molecule therapeutics for neurologic, neuropsychiatric, metabolic, and inflammatory disorders. The company's pipeline includes three product candidates: Ketamir-2, MIRA-55, and SKNY-1, three drug candidates designed to address unmet medical needs across neuropathic and inflammatory pain, central nervous system disorders, and metabolic and behavioral conditions. The company operates as a single operating and reportable segment.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $37.8M